Susquehanna International Group, LLP G1 Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$2.1 - $4.83 $227,640 - $523,572	-108,400 Reduced 72.85%	40,400 $174,000
Q4 2023 Feb 14, 2024	SELL	$1.12 - $3.73 $129,696 - $431,934	-115,800 Reduced 43.76%	148,800 $453,000
Q3 2023 Nov 14, 2023	BUY	$1.22 - $2.67 $18,178 - $39,783	14,900 Added 5.97%	264,600 $381,000
Q2 2023 Aug 11, 2023	BUY	$2.46 - $3.14 $564,324 - $720,316	229,400 Added 1130.05%	249,700 $621,000
Q1 2023 May 16, 2023	SELL	$2.57 - $8.16 $31,867 - $101,184	-12,400 Reduced 37.92%	20,300 $54,000

Q4 2022 Feb 14, 2023	SELL	$5.19 - $13.5 $129,750 - $337,500	-25,000 Reduced 43.33%	32,700 $177,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $189,222 - $621,834	36,600 Added 173.46%	57,700 $721,000
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $18,988 - $39,997	4,700 Added 28.66%	21,100 $104,000
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $46,360 - $67,222	-6,100 Reduced 27.11%	16,400 $125,000
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $607,992 - $1.04 Million	-46,200 Reduced 67.25%	22,500 $302,000
Q2 2021 Aug 11, 2021	SELL	$19.57 - $26.32 $2.82 Million - $3.79 Million	-144,000 Reduced 67.7%	68,700 $1.51 Million
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $3.5 Million - $6.49 Million	199,100 Added 1463.97%	212,700 $5.12 Million
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $50,554 - $93,840	4,600 Added 51.11%	13,600 $245,000
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $2,871 - $7,311	-300 Reduced 3.23%	9,000 $218,000
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $377,936 - $570,400	-18,400 Reduced 66.43%	9,300 $246,000
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $343,978 - $612,758	15,100 Added 119.84%	27,700 $631,000
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $25,648 - $49,760	1,600 Added 14.55%	12,600 $386,000
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $158,400 - $235,950	11,000 New	11,000 $183,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

14.7M

Call Options Held

631K

Put Options Held

347K

Vanguard Group Inc Valley Forge, PA

2.08M
Shares

$5.1 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

904K
Shares

$2.21 Million
0.01% of portfolio
Raymond James & Associates St Petersburg, FL

803K
Shares

$1.97 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

785K
Shares

$1.92 Million
0.0% of portfolio
Black Rock Inc. New York, NY

672K
Shares

$1.65 Million
0.0% of portfolio

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $105M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account